Check-Cap (STU:7CC) Beginning Cash Position: €0.99 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:7CC Check-Cap Ltd STU:7CC
36 GF Score
Price €0.91
! 2 Warning Signs
View Full Analysis

What is Check-Cap Beginning Cash Position?

Check-Cap STU:7CC +1.12% 36 Beginning Cash Position is €0.99 Mil as of Dec. 2025. GuruFocus rates STU:7CC with a GF Score™ of 36/100. The stock has 2 warning signs investors should review.

Check-Cap's Beginning Cash Position for the quarter that ended in Dec. 2025 was €0.99 Mil.

Check-Cap's quarterly Beginning Cash Position declined from Dec. 2024 (€17.02 Mil) to Jun. 2025 (€0.00 Mil) but then increased from Jun. 2025 (€0.00 Mil) to Dec. 2025 (€0.99 Mil).

Check-Cap's annual Beginning Cash Position increased from Dec. 2023 (€4.07 Mil) to Dec. 2024 (€8.45 Mil) but then declined from Dec. 2024 (€8.45 Mil) to Dec. 2025 (€-0.00 Mil).

Check-Cap Beginning Cash Position Related Terms

Check-Cap Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Check-Cap's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Check-Cap Beginning Cash Position Chart

Check-Cap Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.13 25.31 4.07 8.45 -0.00

Check-Cap Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 8.22 17.02 0.00 0.99
STU:7CC
36GF Score
Check-Cap Ltd STU:7CC
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Check-Cap Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of €0.99 Mil mean?
Check-Cap (STU:7CC) has a Beginning Cash Position of €0.99 Mil as of Dec. 2025. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Check-Cap and its competitors.
Is Check-Cap's Beginning Cash Position too high?
Check-Cap's current Beginning Cash Position is €0.99 Mil. Overall, Check-Cap has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Check-Cap's Beginning Cash Position compare to XWEL and NDRA?
Check-Cap's Beginning Cash Position of €0.99 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Diagnostics & Research company?
A good Beginning Cash Position depends on the Medical Diagnostics & Research industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Check-Cap and its competitors. Check-Cap's current Beginning Cash Position is €0.99 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Check-Cap stock overvalued right now?
Check-Cap (STU:7CC) has a current Beginning Cash Position of €0.99 Mil. The current Beginning Cash Position is €0.99 Mil. Check-Cap's overall GF Score™ is 36/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Check-Cap (STU:7CC), the current Beginning Cash Position is €0.99 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Check-Cap Business Description

Other Exchanges MBAI:USA
Address 29 Abba Hushi Avenue, P.O. Box 1271, Mount Carmel, Isfiya, ISR, 3009000
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but plans to market products in the United States, Europe, Israel and Japan.
36GF Score

Get the complete analysis for STU:7CC

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.91
Price